These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. 99mTc-HMPAO washout in prognosis of stroke. Limburg M; van Royen EA; Hijdra A; de Bruine F Lancet; 1989 Apr; 1(8642):839-40. PubMed ID: 2564920 [No Abstract] [Full Text] [Related]
45. 99mTc-HMPAO washout in prognosis of stroke. Costa DC; Ell PJ Lancet; 1989 Jan; 1(8631):213-4. PubMed ID: 2563114 [No Abstract] [Full Text] [Related]
46. Regional cerebral blood flow determined with single photon emission computed tomography and positron emission tomography. A comparative study. Eriksson L; Larsson S; Bergstrand G; Roland P Acta Radiol Suppl; 1986; 369():453-5. PubMed ID: 2980524 [TBL] [Abstract][Full Text] [Related]
47. SPECT with 99Tcm-HMPAO and 99Tcm-pertechnetate to assess regional cerebral blood flow (rCBF) and blood volume (rCBV). Preliminary results in cerebrovascular disease and interictal epilepsy. Buell U; Stirner H; Braun H; Kreiten K; Ferbert A Nucl Med Commun; 1987 Jul; 8(7):519-24. PubMed ID: 2825090 [No Abstract] [Full Text] [Related]
48. CT brainstem abnormalities in the differential diagnosis of Huntington's disease. Masucci EF; Borts FT; Kurtzke JF Comput Med Imaging Graph; 1990; 14(3):205-12. PubMed ID: 2140710 [TBL] [Abstract][Full Text] [Related]
49. The use of [99mTc]-HM-PAO in the diagnosis of primary degenerative dementia. Testa HJ; Snowden JS; Neary D; Shields RA; Burjan AW; Prescott MC; Northen B; Goulding P J Cereb Blood Flow Metab; 1988 Dec; 8(6):S123-6. PubMed ID: 3263978 [TBL] [Abstract][Full Text] [Related]
50. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease. Kuhl DE; Metter EJ; Riege WH; Markham CH Ann Neurol; 1984; 15 Suppl():S119-25. PubMed ID: 6234856 [TBL] [Abstract][Full Text] [Related]
51. 99mTc-HMPAO washout in prognosis of stroke. Steinling M; Lassen NA Lancet; 1989 Mar; 1(8638):619-20. PubMed ID: 2564144 [No Abstract] [Full Text] [Related]
52. Prediction of cerebral palsy in high-risk neonates: a technetium-99m-HMPAO SPECT study. Denays R; VanPachterbeke T; Toppet V; Tondeur M; Spehl M; Piepsz A; Noël P; Haumont D; Ham HR J Nucl Med; 1993 Aug; 34(8):1223-7. PubMed ID: 8326375 [TBL] [Abstract][Full Text] [Related]
53. [Clinical application of 99mTc-HM-PAO in cerebral blood flow imaging by SPECT--comparison with cerebral blood flow study by PET]. Inugami A; Uemura K; Shishido F; Tomura N; Higano S; Fujita H; Kanno I Rinsho Hoshasen; 1988 Feb; 33(2):243-8. PubMed ID: 3260297 [No Abstract] [Full Text] [Related]
54. Cerebellum and brain stem atrophy in a child with Huntington's chorea. Hattori H; Takao T; Ito M; Nakano S; Okuno T; Mikawa H Comput Radiol; 1984; 8(1):53-6. PubMed ID: 6230208 [TBL] [Abstract][Full Text] [Related]
55. Tomographic studies of rCBF with [99mTc]-HM-PAO SPECT in patients with brain tumors: comparison with C15O2 continuous inhalation technique and PET. Langen KJ; Herzog H; Kuwert T; Roosen N; Rota E; Kiwit JC; Bock WJ; Feinendegen LE J Cereb Blood Flow Metab; 1988 Dec; 8(6):S90-4. PubMed ID: 2848045 [TBL] [Abstract][Full Text] [Related]
56. The use of 99Tcm-HM-PAO for the diagnosis of dementia. Smith FW; Gemmell HG; Sharp PF Nucl Med Commun; 1987 Jul; 8(7):525-33. PubMed ID: 2960922 [No Abstract] [Full Text] [Related]